MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

by Yang Liu, Li-Li Lu, Duo Wen, Dong-Li Liu, Li-Li Dong, Dong-Mei Gao, Xin-Yu Bian, Jian Zhou, Jia Fan, Wei-Zhong Wu
Published 2020-02-01

Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

by Yang Liu, Li-Li Lu, Duo Wen, Dong-Li Liu, Li-Li Dong, Dong-Mei Gao, Xin-Yu Bian, Jian Zhou, Jia Fan, Wei-Zhong Wu
Published 2020-05-01

ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway

by Xin Yin, Bei Tang, Jing-Huan Li, Yan Wang, Lan Zhang, Xiao-Ying Xie, Bo-Heng Zhang, Shuang-Jian Qiu, Wei-Zhong Wu, Zheng-Gang Ren
Published 2017-11-01

miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling

by Dong-Min Shi, Li-Xin Li, Xin-Yu Bian, Xue-Jiang Shi, Li-Li Lu, Hong-Xin Zhou, Ting-Jia Pan, Jian Zhou, Jia Fan, Wei-Zhong Wu
Published 2018-11-01

The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.

by Ling-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, Ju-Bo Zhang, Lu Lu, Wen-Quan Wang, Qiang-Bo Zhang, Wei-Zhong Wu, Lu Wang, Jia Fan, Zhao-You Tang, Hui-Chuan Sun
Published 2013-01-01

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.

by Zong-Tao Chai, Jian Kong, Xiao-Dong Zhu, Yuan-Yuan Zhang, Lu Lu, Jia-Min Zhou, Long-Rong Wang, Ke-Zhi Zhang, Qiang-Bo Zhang, Jian-Yang Ao, Miao Wang, Wei-Zhong Wu, Lu Wang, Zhao-You Tang, Hui-Chuan Sun
Published 2013-01-01

Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.

by Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang, Qing-An Jia, Yang Bu, Miao Wang, Zong-Tao Chai, Quan-Bao Zhang, Wen-Quan Wang, Ling-Qun Kong, Xiao-dong Zhu, Lu Lu, Wei-Zhong Wu, Lu Wang, Zhao-You Tang
Published 2013-01-01

Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.

by Lu Lu, Hui-Chuan Sun, Wei Zhang, Zong-Tao Chai, Xiao-Dong Zhu, Ling-Qun Kong, Wen-Quan Wang, Ke-Zhi Zhang, Yuan-Yuan Zhang, Qiang-Bo Zhang, Jian-Yang Ao, Jia-Qi Li, Lu Wang, Wei-Zhong Wu, Zhao-You Tang
Published 2013-01-01